new retatrutide 🎙️ EPISODE: Retatrutide—The Triple Agonist *Not licensed* Will this replace the current GLP-1 in the market., This triple receptor agonist (GIP/GLP-1/glucagon) is showing unprecedented results in Retatrutide clinical trial done! Now

Nothing extreme

(c) comprehensive exam including muscle strength, function, and body composition assessment

Lilly said on July 23, 2026 that it plans to submit its Biologics License Application in Q1 2027

The meal plan above tells you what to eat

That said, combining aerobic exercise (e.g., walking, running, cycling) with strength training (e.g., weightlifting, bodyweight exercises) tends to deliver the best results for weight loss, fat loss , and overall health

While pharmaceutical interventions for enhancing GLP-1 activity exist, exploring natural sources offers a holistic and more sustainable approach to metabolic health